Cryoablation Freezes, Kills Painful Tumors Providing Quick Pain Relief to Cancer Patients, ISET 2014 Study Shows

MIAMI BEACH, Fla.--()--A minimally invasive treatment that quickly freezes and kills tumors provides pain relief to patients whose cancer has spread to the bone and soft tissue, suggests research being presented at the 6th annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).

Cryoablation therapy is a simple, one-time treatment that destroys painful metastatic tumors, meaning cancer that has spread from the primary site in the breast, kidneys, skin and other areas. Standard treatments for pain relief in these patients include narcotic medications and radiation therapy, which often interfere with daily quality of life and may require interruption of chemotherapy treatments.

“Pain can take over the lives of cancer patients and relief of that pain through this simple one-day outpatient procedure can significantly improve time with loved ones,” said J. David Prologo, M.D., lead author of the study, and interventional radiologist at the Centers for Dialysis Care, Cleveland. “It’s very rewarding to see how cryoablation can positively and dramatically impact lives.”

In the study, 51 patients with breast, kidney, skin, lung, prostate, colon and other cancers received cryoablation therapy to treat 54 metastatic tumors that had spread to the pelvic bones, skull, foot, chest wall, shinbone, thighbone, chest wall and other areas. Of the 51 patients, 49 (96 percent) reported statistically significant decreases in pain, scoring an average of eight out of 10 on a pain scale before treatment (with one being the least pain and 10 being the most pain) to an average of three out of 10 after treatment. After three months, 48 patients continued to benefit from pain relief, maintaining the average of three out of 10 on the pain scale. On average, patients decreased the amount of narcotics they took for pain by two-thirds after treatment. Six patients suffered from therapy-related complications, including fractures of treated bones and temporary cryoablation-induced damage to nearby tissues.

In cryoablation, the physician places a probe through the skin into the tumor, turns on the device, which creates an iceball and kills the tissue without destroying the healthy tissue around it. The one-time treatment takes a few hours.

For more about ISET, visit www.ISET.org.

Contacts

Media Contact:
for ISET
Marissa Ellenby, 312-558-1770
mellenby@pcipr.com

Sharing

Contacts

Media Contact:
for ISET
Marissa Ellenby, 312-558-1770
mellenby@pcipr.com